Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 8, 2012, Pages 1216-1222

  Gómez Durán, Aurora ^a   Pacheu Grau, David ^a   Martínez Romero, Íñigo ^a   López Gallardo, Ester ^a   López Pérez, Manuel J ^a   Montoya, Julio ^a   Ruiz Pesini, Eduardo ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Cybrid; Haplogroup; Leber's hereditary optic neuropathy; Mitochondrial DNA; Oxidative phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL DNA; MITOCHONDRIAL RNA;

ARTICLE; CONTROLLED STUDY; CYBRID; HUMAN; HUMAN CELL; LEBER HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL MEMBRANE POTENTIAL; NORMAL HUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; CELL LINE, TUMOR; DNA, MITOCHONDRIAL; HAPLOTYPES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL PROTEINS; OPTIC ATROPHY, HEREDITARY, LEBER; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; POINT MUTATION; RISK FACTORS; RNA;

EID: 84861211027     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.04.014     Document Type: Article

References (50)

1. Yu-Wai-Man P., Griffiths P.G., Chinnery P.F. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res. 2011, 30:81-114.
2. Brown M.D., Sun F., Wallace D.C. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am. J. Hum. Genet. 1997, 60:381-387.
3. Hofmann S., Bezold R., Jaksch M., Obermaier-Kusser B., Mertens S., Kaufhold P., Rabl W., Hecker W., Gerbitz K.D. Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes. Genomics 1997, 39:8-18.
4. Lamminen T., Huoponen K., Sistonen P., Juvonen V., Lahermo P., Aula P., Nikoskelainen E., Savontaus M.L. mtDNA haplotype analysis in Finnish families with leber hereditary optic neuroretinopathy. Eur. J. Hum. Genet. 1997, 5:271-279.
5. Torroni A., Petrozzi M., D'Urbano L., Sellitto D., Zeviani M., Carrara F., Carducci C., Leuzzi V., Carelli V., Barboni P., De Negri A., Scozzari R. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am. J. Hum. Genet. 1997, 60:1107-1121.
6. Hudson G., Carelli V., Spruijt L., Gerards M., Mowbray C., Achilli A., Pyle A., Elson J., Howell N., La Morgia C., Valentino M.L., Huoponen K., Savontaus M.L., Nikoskelainen E., Sadun A.A., Salomao S.R., Belfort R., Griffiths P., Man P.Y., de Coo R.F., Horvath R., Zeviani M., Smeets H.J., Torroni A., Chinnery P.F. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am. J. Hum. Genet. 2007, 81:228-233.
7. Howell N., Herrnstadt C., Shults C., Mackey D.A. Low penetrance of the 14484 LHON mutation when it arises in a non-haplogroup J mtDNA background. Am. J. Med. Genet. A 2003, 119A:147-151.
8. Man P.Y., Griffiths P.G., Brown D.T., Howell N., Turnbull D.M., Chinnery P.F. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am. J. Hum. Genet. 2003, 72:333-339.
9. King M.P., Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989, 246:500-503.
10. Gomez-Duran A., Pacheu-Grau D., Lopez-Gallardo E., Diez-Sanchez C., Montoya J., Lopez-Perez M.J., Ruiz-Pesini E. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum. Mol. Genet. 2010, 19:3343-3353.
11. Bruni F., Polosa P.L., Gadaleta M.N., Cantatore P., Roberti M. Nuclear respiratory factor 2 induces the expression of many but not all human proteins acting in mitochondrial DNA transcription and replication. J. Biol. Chem. 2010, 285:3939-3948.
12. Carelli V., Achilli A., Valentino M.L., Rengo C., Semino O., Pala M., Olivieri A., Mattiazzi M., Pallotti F., Carrara F., Zeviani M., Leuzzi V., Carducci C., Valle G., Simionati B., Mendieta L., Salomao S., Belfort R., Sadun A.A., Torroni A. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am. J. Hum. Genet. 2006, 78:564-574.
13. Suissa S., Wang Z., Poole J., Wittkopp S., Feder J., Shutt T.E., Wallace D.C., Shadel G.S., Mishmar D. Ancient mtDNA genetic variants modulate mtDNA transcription and replication. PLoS Genet. 2009, 5:e1000474.
14. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005, 24:3482-3492.
15. Moreno-Loshuertos R., Acin-Perez R., Fernandez-Silva P., Movilla N., Perez-Martos A., Rodriguez de Cordoba S., Gallardo M.E., Enriquez J.A. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat. Genet. 2006, 38:1261-1268.
16. Parasassi T., Brunelli R., Costa G., De Spirito M., Krasnowska E., Lundeberg T., Pittaluga E., Ursini F. Thiol redox transitions in cell signaling: a lesson from N-acetylcysteine. ScientificWorldJournal 2010, 10:1192-1202.
17. Bellizzi D., Cavalcante P., Taverna D., Rose G., Passarino G., Salvioli S., Franceschi C., De Benedictis G. Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines. Genes Cells 2006, 11:883-891.
18. Bellizzi D., Taverna D., D'Aquila P., De Blasi S., De Benedictis G. Mitochondrial DNA variability modulates mRNA and intra-mitochondrial protein levels of HSP60 and HSP75: experimental evidence from cybrid lines. Cell Stress Chaperones 2009, 14:265-271.
19. Shibanuma M., Kuroki T., Nose K. Inhibition by N-acetyl-l-cysteine of interleukin-6 mRNA induction and activation of NF kappa B by tumor necrosis factor alpha in a mouse fibroblastic cell line, Balb/3T3. FEBS Lett. 1994, 353:62-66.
20. Williams R.S. Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event. J. Biol. Chem. 1986, 261:12390-12394.
21. Welle S., Bhatt K., Shah B., Needler N., Delehanty J.M., Thornton C.A. Reduced amount of mitochondrial DNA in aged human muscle. J. Appl. Physiol. 2003, 94:1479-1484.
22. Coskun P.E., Beal M.F., Wallace D.C. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10726-10731.
23. Cotney J., Wang Z., Shadel G.S. Relative abundance of the human mitochondrial transcription system and distinct roles for h-mtTFB1 and h-mtTFB2 in mitochondrial biogenesis and gene expression. Nucleic Acids Res. 2007, 35:4042-4054.
24. Karamanlidis G., Nascimben L., Couper G.S., Shekar P.S., del Monte F., Tian R. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ. Res. 2010, 106:1541-1548.
25. Kaaman M., Sparks L.M., van Harmelen V., Smith S.R., Sjolin E., Dahlman I., Arner P. Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 2007, 50:2526-2533.
26. Rocher C., Taanman J.W., Pierron D., Faustin B., Benard G., Rossignol R., Malgat M., Pedespan L., Letellier T. Influence of mitochondrial DNA level on cellular energy metabolism: implications for mitochondrial diseases. J. Bioenerg. Biomembr. 2008, 40:59-67.
27. Fernandez-Vizarra E., Enriquez J.A., Perez-Martos A., Montoya J., Fernandez-Silva P. Tissue-specific differences in mitochondrial activity and biogenesis. Mitochondrion 2011, 11:207-213.
28. Pello R., Martin M.A., Carelli V., Nijtmans L.G., Achilli A., Pala M., Torroni A., Gomez-Duran A., Ruiz-Pesini E., Martinuzzi A., Smeitink J.A., Arenas J., Ugalde C. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum. Mol. Genet. 2008, 17:4001-4011.
29. Marcuello A., Martinez-Redondo D., Dahmani Y., Casajus J.A., Ruiz-Pesini E., Montoya J., Lopez-Perez M.J., Diez-Sanchez C. Human mitochondrial variants influence on oxygen consumption. Mitochondrion 2009, 9:27-30.
30. Martinez-Redondo D., Marcuello A., Casajus J.A., Ara I., Dahmani Y., Montoya J., Ruiz-Pesini E., Lopez-Perez M.J., Diez-Sanchez C. Human mitochondrial haplogroup H: the highest VO2max consumer-is it a paradox?. Mitochondrion 2010, 10:102-107.
31. Bentlage H.A., Attardi G. Relationship of genotype to phenotype in fibroblast-derived transmitochondrial cell lines carrying the 3243 mutation associated with the MELAS encephalomyopathy: shift towards mutant genotype and role of mtDNA copy number. Hum. Mol. Genet. 1996, 5:197-205.
32. Laderman K.A., Penny J.R., Mazzucchelli F., Bresolin N., Scarlato G., Attardi G. Aging-dependent functional alterations of mitochondrial DNA (mtDNA) from human fibroblasts transferred into mtDNA-less cells. J. Biol. Chem. 1996, 271:15891-15897.
33. Li Y., Li H.Z., Hu P., Deng J., Banoei M.M., Sharma L.K., Bai Y. Generation and bioenergetic analysis of cybrids containing mitochondrial DNA from mouse skeletal muscle during aging. Nucleic Acids Res. 2010, 38:1913-1921.
34. Barrientos A., Moraes C.T. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 1999, 274:16188-16197.
35. McKenzie M., Liolitsa D., Akinshina N., Campanella M., Sisodiya S., Hargreaves I., Nirmalananthan N., Sweeney M.G., Abou-Sleiman P.M., Wood N.W., Hanna M.G., Duchen M.R. Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption. J. Biol. Chem. 2007, 282:36845-36852.
36. Kulawiec M., Owens K.M., Singh K.K. mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J. Hum. Genet. 2009, 54:647-654.
37. Hinttala R., Kervinen M., Uusimaa J., Maliniemi P., Finnila S., Rantala H., Remes A.M., Hassinen I.E., Majamaa K. Analysis of functional consequences of haplogroup J polymorphisms m.4216T>C and m.3866T>C in human MT-ND1: mutagenesis of homologous positions in Escherichia coli. Mitochondrion 2010, 10:358-361.
38. Beckstead W.A., Ebbert M.T., Rowe M.J., McClellan D.A. Evolutionary pressure on mitochondrial cytochrome b is consistent with a role of CytbI7T affecting longevity during caloric restriction. PLoS One 2009, 4:e5836.
39. Desquiret V., Loiseau D., Jacques C., Douay O., Malthiery Y., Ritz P., Roussel D. Dinitrophenol-induced mitochondrial uncoupling in vivo triggers respiratory adaptation in HepG2 cells. Biochim. Biophys. Acta 2006, 1757:21-30.
40. Hwang S., Kwak S.H., Bhak J., Kang H.S., Lee Y.R., Koo B.K., Park K.S., Lee H.K., Cho Y.M. Gene expression pattern in transmitochondrial cytoplasmic hybrid cells harboring type 2 diabetes-associated mitochondrial DNA haplogroups. PLoS One 2011, 6:e22116.
41. Butow R.A., Avadhani N.G. Mitochondrial signaling: the retrograde response. Mol. Cell 2004, 14:1-15.
42. Finley L.W., Haigis M.C. The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res. Rev. 2009, 8:173-188.
43. Kazuno A.A., Munakata K., Nagai T., Shimozono S., Tanaka M., Yoneda M., Kato N., Miyawaki A., Kato T. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet. 2006, 2:e128.
44. Arning L., Haghikia A., Taherzadeh-Fard E., Saft C., Andrich J., Pula B., Hoxtermann S., Wieczorek S., Akkad D.A., Perrech M., Gold R., Epplen J.T., Chan A. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease. J. Mol. Med. 2010, 88:431-436.
45. Houshmand M., Sharifpanah F., Tabasi A., Sanati M.H., Vakilian M., Lavasani S.H., Joughehdoust S. Leber's hereditary optic neuropathy: the spectrum of mitochondrial DNA mutations in Iranian patients. Ann. N. Y. Acad. Sci. 2004, 1011:345-349.
46. Quintana-Murci L., Chaix R., Wells R.S., Behar D.M., Sayar H., Scozzari R., Rengo C., Al-Zahery N., Semino O., Santachiara-Benerecetti A.S., Coppa A., Ayub Q., Mohyuddin A., Tyler-Smith C., Qasim Mehdi S., Torroni A., McElreavey K. Where west meets east: the complex mtDNA landscape of the southwest and Central Asian corridor. Am. J. Hum. Genet. 2004, 74:827-845.
47. Giordano C., Montopoli M., Perli E., Orlandi M., Fantin M., Ross-Cisneros F.N., Caparrotta L., Martinuzzi A., Ragazzi E., Ghelli A., Sadun A.A., d'Amati G., Carelli V. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011, 134:220-234.
48. Nishioka T., Soemantri A., Ishida T. mtDNA/nDNA ratio in 14484 LHON mitochondrial mutation carriers. J. Hum. Genet. 2004, 49:701-705.
49. Kirkman M.A., Yu-Wai-Man P., Korsten A., Leonhardt M., Dimitriadis K., De Coo I.F., Klopstock T., Chinnery P.F. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009, 132:2317-2326.
50. Bouhours-Nouet N., May-Panloup P., Coutant R., de Casson F.B., Descamps P., Douay O., Reynier P., Ritz P., Malthiery Y., Simard G. Maternal smoking is associated with mitochondrial DNA depletion and respiratory chain complex III deficiency in placenta. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E171-E177.